Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L

por Labriet, Adrien, De Mattia, Elena, Cecchin, Erika, Lévesque, Éric, Jonker, Derek, Couture, Félix, Buonadonna, Angela, D’Andrea, Mario, Villeneuve, Lyne, Toffoli, Giuseppe, Guillemette, Chantal
Publicado 2017

IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm

por De Mattia, Elena, Polesel, Jerry, Roncato, Rossana, Labriet, Adrien, Bignucolo, Alessia, Gagno, Sara, Buonadonna, Angela, D’Andrea, Mario, Lévesque, Eric, Jonker, Derek, Couture, Félix, Guillemette, Chantal, Cecchin, Erika, Toffoli, Giuseppe
Publicado 2021

Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients

por Labriet, Adrien, Lévesque, Éric, Cecchin, Erika, De Mattia, Elena, Villeneuve, Lyne, Rouleau, Michèle, Jonker, Derek, Couture, Félix, Simonyan, David, Allain, Eric P., Buonadonna, Angela, D’Andrea, Mario, Toffoli, Giuseppe, Guillemette, Chantal
Publicado 2019

Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients

por De Mattia, Elena, Cecchin, Erika, Montico, Marcella, Labriet, Adrien, Guillemette, Chantal, Dreussi, Eva, Roncato, Rossana, Bignucolo, Alessia, Buonadonna, Angela, D’Andrea, Mario, Coppola, Luigi, Lonardi, Sara, Lévesque, Eric, Jonker, Derek, Couture, Félix, Toffoli, Giuseppe
Publicado 2018

Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI

por De Mattia, Elena, Polesel, Jerry, Roncato, Rossana, Labriet, Adrien, Bignucolo, Alessia, Dreussi, Eva, Romanato, Loredana, Guardascione, Michela, Buonadonna, Angela, D'Andrea, Mario, Lévesque, Eric, Jonker, Derek, Couture, Félix, Guillemette, Chantal, Cecchin, Erika, Toffoli, Giuseppe
Publicado 2019

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression

por Lévesque, Eric, Labriet, Adrien, Hovington, Hélène, Allain, Éric P., Melo-Garcia, Luciana, Rouleau, Michèle, Brisson, Hervé, Turcotte, Véronique, Caron, Patrick, Villeneuve, Lyne, Leclercq, Mickaël, Droit, Arnaud, Audet-Walsh, Etienne, Simonyan, David, Fradet, Yves, Lacombe, Louis, Guillemette, Chantal
Publicado 2020

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

por Allain, Eric P., Rouleau, Michèle, Vanura, Katrina, Tremblay, Sophie, Vaillancourt, Joanie, Bat, Vincent, Caron, Patrick, Villeneuve, Lyne, Labriet, Adrien, Turcotte, Véronique, Le, Trang, Shehata, Medhat, Schnabl, Susanne, Demirtas, Dita, Hubmann, Rainer, Joly-Beauparlant, Charles, Droit, Arnaud, Jäger, Ulrich, Staber, Philipp B., Lévesque, Eric, Guillemette, Chantal
Publicado 2020